Legend Biotech Corp. reported a robust performance for Q4 2024, driven by a significant increase in CARVICTI sales. The company achieved net sales of $334 million for CARVICTI, marking a 110% ...
Legend Power Systems, with a market capitalization of $19 million, reported significant growth in its first-quarter earnings, marking a notable improvement in financial performance. The company ...
Legend Biotech Corp (LEGN) reported its second-quarter earnings for 2025, revealing a significant increase in revenue but a larger-than-expected loss per share. The company’s revenue reached 255.06 ...
Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback